Tenaya Therapeutics
TNYA
74 hedge funds and large institutions have $151M invested in Tenaya Therapeutics in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 12 closing their positions.
3,400% more call options, than puts
Call options by funds: $35K | Put options by funds: $1K
19% more capital invested
Capital invested by funds: $127M → $151M (+$24.6M)
13% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 24
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3% less funds holding
Funds holding: 76 → 74 (-2)
4.66% less ownership
Funds ownership: 73.23% → 68.57% (-4.7%)
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$629K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$411K |
| 3 |
Morgan Stanley
New York
|
+$319K |
| 4 |
Squarepoint
New York
|
+$255K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$232K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$2.61M |
| 2 |
BlackRock
New York
|
-$1.93M |
| 3 |
HMC
Harvard Management Company
Boston,
Massachusetts
|
-$1.72M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.15M |
| 5 |
Millennium Management
New York
|
-$507K |
TNYA Hedge Fund Activity: Q4 2023 in Review
74 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q4 2023, worth a combined $151M — up 19% from $127M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of TNYA and 10 opened new positions — a net loss of 2 holders — while 24 trimmed existing stakes and 27 added.
The largest buyer was Vanguard Group, adding an estimated $629K. The largest seller was RA Capital Management, cutting an estimated $2.61M.
- 74 institutional investors held Tenaya Therapeutics (TNYA) as of Q4 2023, down from 76 in Q3 2023.
- Funds reported $151M of Tenaya Therapeutics stock for Q4 2023, up 19% quarter-over-quarter.
- 10 funds opened new Tenaya Therapeutics positions in Q4 2023 and 12 closed out, a net change of -2 holders.
- The largest Tenaya Therapeutics buyer in Q4 2023 was Vanguard Group, an estimated $629K added.
- The largest Tenaya Therapeutics seller in Q4 2023 was RA Capital Management, an estimated $2.61M sold.
Based on aggregated 13F filings for Q4 2023.